An Open-label, Randomized, Single Administration, Full Replicated Crossover Phase 1 Clinical Trial to Compare Pharmacokinetics and Safety Between JLP-1901 and JC-001 in Healthy Subjects
Latest Information Update: 21 Dec 2023
At a glance
- Drugs JLP 1901 (Primary) ; JLP 2008; Tenofovir
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
Most Recent Events
- 21 Dec 2023 New trial record